News & Perspective

(CIDRAP News) – With tougher security requirements set to take effect next April, few state public health laboratories plan to maintain stocks of certain pathogens considered most tempting to bioterrorists, according to the Association of Public Health Laboratories (APHL) and officials with state labs.

(CIDRAP News) – The Centers for Disease Control and Prevention (CDC) has revised its list of potentially dangerous biological agents and toxins and the regulations covering them, and some of the changes have public health laboratories concerned.

(CIDRAP News) – The National Institutes of Health (NIH) yesterday announced it has awarded contracts, which could total $150 million over 5 years, to four companies to develop broad-spectrum therapies that could help the nation respond to a bioterror attack or other public health emergency.

(CIDRAP News) – A federal advisory committee is recommending that 11 bacterial species and viruses on the current "select agent" list, including anthrax and Ebola virus, be singled out for special safeguards and that another 19 agents be dropped from the list entirely.

(CIDRAP News) – The National Research Council (NRC), in a letter report, has advised the US Army to prepare a more comprehensive risk assessment than it initially proposed for a biodefense laboratory to be built at Ft. Detrick in Frederick, Md.

(CIDRAP News) – The US Department of Health and Human Services (HHS) has awarded a contract to a San Francisco company to further the development of a new broad-spectrum antibiotic for treating plague, tularemia, and various resistant infections.